309 related articles for article (PubMed ID: 12897068)
1. Critical role of microglial NADPH oxidase-derived free radicals in the in vitro MPTP model of Parkinson's disease.
Gao HM; Liu B; Zhang W; Hong JS
FASEB J; 2003 Oct; 17(13):1954-6. PubMed ID: 12897068
[TBL] [Abstract][Full Text] [Related]
2. Synergistic dopaminergic neurotoxicity of MPTP and inflammogen lipopolysaccharide: relevance to the etiology of Parkinson's disease.
Gao HM; Liu B; Zhang W; Hong JS
FASEB J; 2003 Oct; 17(13):1957-9. PubMed ID: 12923073
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotective effect of dextromethorphan in the MPTP Parkinson's disease model: role of NADPH oxidase.
Zhang W; Wang T; Qin L; Gao HM; Wilson B; Ali SF; Zhang W; Hong JS; Liu B
FASEB J; 2004 Mar; 18(3):589-91. PubMed ID: 14734632
[TBL] [Abstract][Full Text] [Related]
4. Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson's disease.
Zhang W; Wang T; Pei Z; Miller DS; Wu X; Block ML; Wilson B; Zhang W; Zhou Y; Hong JS; Zhang J
FASEB J; 2005 Apr; 19(6):533-42. PubMed ID: 15791003
[TBL] [Abstract][Full Text] [Related]
5. A pivotal role of matrix metalloproteinase-3 activity in dopaminergic neuronal degeneration via microglial activation.
Kim YS; Choi DH; Block ML; Lorenzl S; Yang L; Kim YJ; Sugama S; Cho BP; Hwang O; Browne SE; Kim SY; Hong JS; Beal MF; Joh TH
FASEB J; 2007 Jan; 21(1):179-87. PubMed ID: 17116747
[TBL] [Abstract][Full Text] [Related]
6. Critical role for microglial NADPH oxidase in rotenone-induced degeneration of dopaminergic neurons.
Gao HM; Liu B; Hong JS
J Neurosci; 2003 Jul; 23(15):6181-7. PubMed ID: 12867501
[TBL] [Abstract][Full Text] [Related]
7. Minocycline attenuates microglial activation but fails to mitigate striatal dopaminergic neurotoxicity: role of tumor necrosis factor-alpha.
Sriram K; Miller DB; O'Callaghan JP
J Neurochem; 2006 Feb; 96(3):706-18. PubMed ID: 16405514
[TBL] [Abstract][Full Text] [Related]
8. 3-hydroxymorphinan is neurotrophic to dopaminergic neurons and is also neuroprotective against LPS-induced neurotoxicity.
Zhang W; Qin L; Wang T; Wei SJ; Gao HM; Liu J; Wilson B; Liu B; Zhang W; Kim HC; Hong JS
FASEB J; 2005 Mar; 19(3):395-7. PubMed ID: 15596482
[TBL] [Abstract][Full Text] [Related]
9. Paroxetine prevents loss of nigrostriatal dopaminergic neurons by inhibiting brain inflammation and oxidative stress in an experimental model of Parkinson's disease.
Chung YC; Kim SR; Jin BK
J Immunol; 2010 Jul; 185(2):1230-7. PubMed ID: 20566832
[TBL] [Abstract][Full Text] [Related]
10. Nrf2 regulates microglial dynamics and neuroinflammation in experimental Parkinson's disease.
Rojo AI; Innamorato NG; Martín-Moreno AM; De Ceballos ML; Yamamoto M; Cuadrado A
Glia; 2010 Apr; 58(5):588-98. PubMed ID: 19908287
[TBL] [Abstract][Full Text] [Related]
11. Deficiency of TNF receptors suppresses microglial activation and alters the susceptibility of brain regions to MPTP-induced neurotoxicity: role of TNF-alpha.
Sriram K; Matheson JM; Benkovic SA; Miller DB; Luster MI; O'Callaghan JP
FASEB J; 2006 Apr; 20(6):670-82. PubMed ID: 16581975
[TBL] [Abstract][Full Text] [Related]
12. Ultrafine carbon particles promote rotenone-induced dopamine neuronal loss through activating microglial NADPH oxidase.
Wang Y; Liu D; Zhang H; Wang Y; Wei L; Liu Y; Liao J; Gao HM; Zhou H
Toxicol Appl Pharmacol; 2017 May; 322():51-59. PubMed ID: 28283350
[TBL] [Abstract][Full Text] [Related]
13. MPP+-induced COX-2 activation and subsequent dopaminergic neurodegeneration.
Wang T; Pei Z; Zhang W; Liu B; Langenbach R; Lee C; Wilson B; Reece JM; Miller DS; Hong JS
FASEB J; 2005 Jul; 19(9):1134-6. PubMed ID: 15845609
[TBL] [Abstract][Full Text] [Related]
14. Nitric oxide and reactive oxygen species in Parkinson's disease.
Tieu K; Ischiropoulos H; Przedborski S
IUBMB Life; 2003 Jun; 55(6):329-35. PubMed ID: 12938735
[TBL] [Abstract][Full Text] [Related]
15. Macrophage antigen complex-1 mediates reactive microgliosis and progressive dopaminergic neurodegeneration in the MPTP model of Parkinson's disease.
Hu X; Zhang D; Pang H; Caudle WM; Li Y; Gao H; Liu Y; Qian L; Wilson B; Di Monte DA; Ali SF; Zhang J; Block ML; Hong JS
J Immunol; 2008 Nov; 181(10):7194-204. PubMed ID: 18981141
[TBL] [Abstract][Full Text] [Related]
16. Prothrombin kringle-2-induced oxidative stress contributes to the death of cortical neurons in vivo and in vitro: role of microglial NADPH oxidase.
Won SY; Choi SH; Jin BK
J Neuroimmunol; 2009 Sep; 214(1-2):83-92. PubMed ID: 19660816
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of 6-hydroxydopamine neurotoxicity: the role of NADPH oxidase and microglial activation in 6-hydroxydopamine-induced degeneration of dopaminergic neurons.
Rodriguez-Pallares J; Parga JA; Muñoz A; Rey P; Guerra MJ; Labandeira-Garcia JL
J Neurochem; 2007 Oct; 103(1):145-56. PubMed ID: 17573824
[TBL] [Abstract][Full Text] [Related]
18. Clozapine metabolites protect dopaminergic neurons through inhibition of microglial NADPH oxidase.
Jiang L; Wu X; Wang S; Chen SH; Zhou H; Wilson B; Jin CY; Lu RB; Xie K; Wang Q; Hong JS
J Neuroinflammation; 2016 May; 13(1):110. PubMed ID: 27184631
[TBL] [Abstract][Full Text] [Related]
19. Proteomic analysis of microglial contribution to mouse strain-dependent dopaminergic neurotoxicity.
McLaughlin P; Zhou Y; Ma T; Liu J; Zhang W; Hong JS; Kovacs M; Zhang J
Glia; 2006 Apr; 53(6):567-82. PubMed ID: 16419087
[TBL] [Abstract][Full Text] [Related]
20. Sinomenine, a natural dextrorotatory morphinan analog, is anti-inflammatory and neuroprotective through inhibition of microglial NADPH oxidase.
Qian L; Xu Z; Zhang W; Wilson B; Hong JS; Flood PM
J Neuroinflammation; 2007 Sep; 4():23. PubMed ID: 17880684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
